Literature DB >> 8621551

Cortisol inhibits the synthesis of insulin-like growth factor-binding protein-5 in bone cell cultures by transcriptional mechanisms.

B Gabbitas1, J M Pash, A M Delany, E Canalis.   

Abstract

Glucocorticoids inhibit the synthesis of insulin-like growth factor-binding protein-5 (IGFBP-5) in osteoblasts, but the mechanisms involved are unknown. IGFBP-5 stimulates bone cell growth, and its inhibition by glucocorticoids may be relevant to the action of this binding protein on bone formation. We tested the effects of cortisol on IGFBP-5 expression in cultures of osteoblast-enriched cells from fetal rat calvariae (Ob cells). Cortisol decreased IGFBP-5 polypeptide levels in the extracellular matrix and caused a time- and dose-dependent decrease in IGFBP-5 mRNA. IGFBP-5 transcripts were markedly decreased by cycloheximide, and further suppressive effects of cortisol could not be determined. Cortisol did not modify the decay of IGFBP-5 mRNA in transcriptionally arrested Ob cells. Cortisol decreased IGFBP-5 hnRNA, the rate of IGFBP-5 transcription, and the activity of the murine IGFBP-5 promoter by 35% in transient transfection experiments. Deletion analysis showed that the region responsive to cortisol is from base pairs -70 to +22, and E-box-binding proteins or c-Myb-related nuclear factors may be involved in its regulation. In conclusion, cortisol inhibits IGFBP-5 transcription in Ob cells through the Myb-binding domain. This effect may be partly responsible for the effect of glucocorticoids on bone formation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621551     DOI: 10.1074/jbc.271.15.9033

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Glucocorticoid-Induced Osteoporosis.

Authors:  Baruch Frenkel; Wendy White; Jan Tuckermann
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

2.  Nuclear factor I transcription factors regulate IGF binding protein 5 gene transcription in human osteoblasts.

Authors:  Laura A Pérez-Casellas; Xiaoying Wang; Kristy D Howard; Mark W Rehage; Donna D Strong; Thomas A Linkhart
Journal:  Biochim Biophys Acta       Date:  2008-09-10

3.  Orphaning stunts growth in wild African elephants.

Authors:  Jenna M Parker; George Wittemyer
Journal:  Conserv Physiol       Date:  2022-07-30       Impact factor: 3.252

Review 4.  Glucocorticoid-induced osteoporosis: pathophysiology and therapy.

Authors:  E Canalis; G Mazziotti; A Giustina; J P Bilezikian
Journal:  Osteoporos Int       Date:  2007-06-14       Impact factor: 4.507

Review 5.  Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis.

Authors:  James Beattie; Gordon J Allan; Jennifer D Lochrie; David J Flint
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

6.  Gene expression analysis in human osteoblasts exposed to dexamethasone identifies altered developmental pathways as putative drivers of osteoporosis.

Authors:  Conor J Hurson; Joseph S Butler; Dominic T Keating; David W Murray; Denise M Sadlier; John M O'Byrne; Peter P Doran
Journal:  BMC Musculoskelet Disord       Date:  2007-02-12       Impact factor: 2.362

7.  Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2.

Authors:  Teng-Teng L L Chung; Li F Chan; Louise A Metherell; Adrian J L Clark
Journal:  Clin Endocrinol (Oxf)       Date:  2009-06-24       Impact factor: 3.478

Review 8.  Multifunctional roles of insulin-like growth factor binding protein 5 in breast cancer.

Authors:  Mustafa Akkiprik; Yumei Feng; Huamin Wang; Kexin Chen; Limei Hu; Aysegul Sahin; Savitri Krishnamurthy; Ayse Ozer; Xishan Hao; Wei Zhang
Journal:  Breast Cancer Res       Date:  2008-08-11       Impact factor: 6.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.